Pal-Gly-Gln-Pro-Arg-OH游离态

PALMITOYL TETRAPEPTIDE-7 [INCI] | l-Arginine, N-(1-oxohexadecyl)glycyl-l-glutaminyl-l-prolyl- | Palmitoyl-GQPR | HY-P0064 | MFCD11977710 | Pal-Gly-Gln-Pro-Arg-OH | Palmitoyl Tetrapeptide-3 | (S)-2-[(S)-1-[(S)-5-Amino-5-oxo-2-(2-palmitamidoacetamido)pentan

P292761-100mg

100mg

≥98%

It can delay and inhibit the production of excessive cell interleukin, thereby inhibiting some unnecessary and inappropriate inflammation and glycosylation damage. Efficacy and Mechanism of Action Palmitoyl tetrapeptide-7 (Rigin TM) (sequence: Pal-Gly-Gln-Pro-Arg or pal-GQPR) is a fragment of immunoglobulin G. Palmitoyl tetrapeptide-7 reduces IL-6 secretion in the basic environment and is used as an anti-inflammatory agent after exposure to UVB radiation. In vivo reflection confocal microscopy showed that the mixture of palmitoyl oligopeptide and palmitoyl tetrapeptide-7 enhanced the structure of extracellular matrix compared with placebo. It can delay and inhibit the production of excessive cell interleukin, thereby inhibiting some unnecessary and inappropriate inflammation and glycosylation damage. Efficacy and Mechanism of Action Palmitoyl tetrapeptide-7 (Rigin TM) (sequence: Pal-Gly-Gln-Pro-Arg or pal-GQPR) is a fragment of immunoglobulin G. Palmitoyl tetrapeptide-7 reduces IL-6 secretion in the basic environment and is used as an anti-inflammatory agent after exposure to UVB radiation. In vivo reflection confocal microscopy showed that the mixture of palmitoyl oligopeptide and palmitoyl tetrapeptide-7 enhanced the structure of extracellular matrix compared with placebo.

Pal-Gly-Gln-Pro-Arg